Fort Worth Patient Shows Progress in Cancer Fight
Young neuroblastoma patient regains leg movement following intensive MIBG therapy in Fort Worth.
Updated on Oct. 23, 2026 in Cancer
Ten-year-old Ember Harguess is showing positive results in her neuroblastoma treatment after undergoing MIBG therapy. The young patient has regained movement in her legs after previously losing control of her limbs during her medical battle.
Why it matters
The successful response to treatment marks a significant milestone for the young patient and her family. Her progress follows a difficult period that prompted the family to transfer her care to a specialized medical facility.
Medical scans confirm that the neuroblastoma is currently responding to radiation therapy injected into the body. This response follows a period where the 10-year-old patient experienced a total loss of control in her legs.
The players
Ember Harguess
The 10-year-old patient who recently regained leg movement while undergoing treatment for neuroblastoma.
Cook Children's Medical Center
A Fort Worth-based medical facility that provided specialized MIBG therapy for the patient.
The details
After the family transferred care to Cook Children's Medical Center in Fort Worth, doctors administered MIBG therapy to target the cancer. The treatment proved effective, allowing the child to regain physical mobility after the condition had initially caused her to lose the use of her legs.
Timeline
Late 2024: Ember Harguess began her battle with neuroblastoma.
October 2025: Reporters spoke with the Harguess family.
October 23, 2026: News report published regarding positive treatment progress.
November 23, 2026: Ember Harguess turns 11 years old.
Health Landscape
The application of MIBG therapy for neuroblastoma has become a standard approach for addressing aggressive pediatric tumors. This case reflects broader advancements in pediatric oncology where targeted systemic radiation is used to stabilize patients who have experienced severe neurological complications.
This progress highlights the potential for regaining mobility in patients suffering from neuroblastoma-related nerve damage. Families facing similar diagnoses should consult with oncology specialists regarding the availability of targeted MIBG therapy options.
The takeaway
The successful treatment outcome underscores the importance of seeking specialized care for aggressive pediatric cancers. Families should maintain open communication with medical teams to monitor functional recovery progress closely.
Further reading
For more information on pediatric oncology treatments, see the Cancer section.
Source note: This article includes information reported by KLRT - FOX16.com.
